Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Director/PDMR Shareholding

22 Jan 2016 15:31

RNS Number : 7785M
First Derivatives PLC
22 January 2016
 

22 January 2016

First Derivatives plc

("FD" or the "Company")

 

Director's Shareholding

 

FD (AIM: FDP.L, ESM: FDP.I), a leading provider of software and consulting services, announces that Seamus Keating, Chairman, has today acquired 10,000 ordinary shares of 0.5 pence per share in the Company ("Ordinary Shares") at a price of 1,550p per share. Following the transaction, Mr. Keating now has an interest in 25,314 Ordinary Shares, representing 0.1% of the Company's issued share capital.

For further information please contact:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Investec Bank plc

(Nominated Adviser and Broker)

Dominic Emery

Sebastian Lawrence

+44 (0)20 7597 4000

Goodbody (ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Walbrook PR

Paul Cornelius

Nick Rome

Helen Cresswell

Sam Allen

+44 (0)20 7933 8780

 

 

About FD

FD is a global technology provider with 20 years of experience. The Group's Kx technology is used by some of the world's largest finance, technology and energy institutions. FD employs over 1,500 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Tokyo, Sydney, Palo Alto, Toronto, Philadelphia, Dublin, Belfast and its headquarters in Newry.

 

For further information, please visit www.firstderivatives.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSESFIEFMSEDF
Date   Source Headline
2nd Feb 20229:33 amRNSHolding(s) in Company
20th Jan 20227:00 amRNSDirectorate Change
17th Jan 20227:00 amRNSDirector/PDMR Shareholding
31st Dec 202110:10 amRNSTotal Voting Rights
13th Dec 20212:59 pmRNSIssue of Equity
9th Dec 20219:40 amRNSDirector/PDMR Shareholding
1st Dec 20211:55 pmRNSHolding(s) in Company
30th Nov 202110:52 amRNSTotal Voting Rights
18th Nov 20217:00 amRNSAppointment of Adviser
15th Nov 20215:12 pmRNSIssue of Equity
9th Nov 20218:48 amRNSHolding(s) in Company
2nd Nov 20217:00 amRNSResults for the six months ended 31 August 2021
11th Oct 20217:00 amRNSHolding(s) in Company
6th Oct 20214:27 pmRNSHolding(s) in Company
6th Oct 20217:00 amRNSNotice of Results
1st Sep 20219:29 amRNSTotal Voting Rights
25th Aug 20215:37 pmRNSIssue of Equity
11th Aug 20217:00 amRNSLTIP Award
30th Jul 20217:00 amRNSDirectorate Change
8th Jul 20215:23 pmRNSResult of AGM
2nd Jul 202111:47 amRNSHolding(s) in Company
30th Jun 202112:16 pmRNSTotal Voting Rights
22nd Jun 20215:44 pmRNSIssue of Equity
15th Jun 20211:20 pmRNSHolding(s) in Company
14th Jun 20215:05 pmRNSHolding(s) in Company
8th Jun 20215:19 pmRNSNotice of AGM & Change of Name
1st Jun 202110:31 amRNSTotal Voting Rights
26th May 20214:06 pmRNSHolding(s) in Company
25th May 20216:08 pmRNSIssue of Equity
18th May 20217:00 amRNSFull Year Results
13th Apr 20217:00 amRNSTrading Update
31st Mar 202110:29 amRNSTotal Voting Rights
3rd Mar 20216:13 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAppointment of Scott Matthews as CEO for MRP
1st Mar 20217:00 amRNSAppointment of Eric Raab as KX CTO
26th Feb 20214:18 pmRNSIssue of Equity
26th Feb 20219:25 amRNSTotal Voting Rights
23rd Feb 20217:00 amRNSPartial sale of Quantile Technologies holding
15th Feb 20214:28 pmRNSIssue of Equity
29th Jan 20219:59 amRNSTotal Voting Rights
25th Jan 20216:18 pmRNSIssue of Equity
31st Dec 202011:17 amRNSTotal Voting Rights
9th Dec 20207:00 amRNSDirectorate Change
8th Dec 202012:46 pmRNSIssue of Equity
30th Nov 20209:35 amRNSTotal Voting Rights
16th Nov 20203:21 pmRNSHolding(s) in Company
13th Nov 20204:08 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSResult of secondary placing
30th Oct 20201:30 pmRNSIssue of Equity
27th Oct 20207:00 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.